Immunotec Reports Continued Growth in U.S. Sales

Growing U.S. sales sustained third-quarter momentum at Immunotec (IMM—TSX), the nutrition company said in an earnings report released Thursday.

Quebec-based Immunotec posted a 31 percent increase in U.S. sales for the quarter ended July 31, primarily due to a 37 percent jump in new U.S. consultants and customers. By contrast, sponsoring activities in Mexico fell 20.6 percent from a year ago, where the market continues to adjust to a 16 percent value-added tax introduced by Immunotec in October 2014.

Quarterly revenue totaled $16.8 million, comparable to $16.9 million a year ago. In the first three quarters of the year, cumulative revenue increased 4.3 percent versus the same period in 2014.

Adjusted EBITDA also remained flat at $1.1 million, the publicly traded company reported. Net profit was $910,505, compared to a loss of $3.3 million a year ago.


About Direct Selling News
Direct Selling News Magazine has been serving direct selling and network marketing executives since 2004. Each issue of Direct Selling News offers content on topics that shape the dynamics of our industry.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: